Viyash Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Viyash Scientific Limited (SEQUENT) share price today for real-time trading data and today's change.

Viyash Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Viyash Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Viyash Scientific Limited market cap and net worth for the company's overall valuation and market capitalisation.

Viyash Scientific Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Viyash Scientific Limited ranked by their cash flow conversion efficiency. Also see SEQUENT current and non-current assets for a full breakdown of the balance sheet.

Company Cash Flow Conversion Efficiency
Start Group
SHG:600734
-0.075x
Zhe Jiang Li Zi Yuan Food Co Ltd
SHG:605337
0.147x
Shandong Shengli Co Ltd
SHE:000407
0.110x
Allied Electronics Corporation Ltd
JSE:AEL
0.163x
Empresa Distribuidora y Comercializadora Norte S.A.
BA:EDN
0.024x
Pangaea Logistic
NASDAQ:PANL
0.061x
Pagerduty Inc
NYSE:PD
0.094x
ZJBC Information Technology Co Ltd
SHE:000889
0.058x

Annual Cash Flow Conversion Efficiency for Viyash Scientific Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Viyash Scientific Limited from 2006 to 2025. Review financial flexibility index of Viyash Scientific Limited to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs7.70 Billion
≈ $83.31 Million
Rs833.60 Million
≈ $9.02 Million
0.108x +152.16%
2024-03-31 Rs7.13 Billion
≈ $77.10 Million
Rs305.95 Million
≈ $3.31 Million
0.043x +91.28%
2023-03-31 Rs7.49 Billion
≈ $81.02 Million
Rs168.08 Million
≈ $1.82 Million
0.022x -45.73%
2022-03-31 Rs7.40 Billion
≈ $80.04 Million
Rs305.95 Million
≈ $3.31 Million
0.041x -72.03%
2021-03-31 Rs7.76 Billion
≈ $83.96 Million
Rs1.15 Billion
≈ $12.41 Million
0.148x -6.20%
2020-03-31 Rs7.32 Billion
≈ $79.15 Million
Rs1.15 Billion
≈ $12.47 Million
0.158x +1.45%
2019-03-31 Rs7.47 Billion
≈ $80.78 Million
Rs1.16 Billion
≈ $12.55 Million
0.155x +135.05%
2018-03-31 Rs6.85 Billion
≈ $74.03 Million
Rs452.39 Million
≈ $4.89 Million
0.066x +1013.61%
2017-03-31 Rs9.94 Billion
≈ $107.50 Million
Rs-71.90 Million
≈ $-777.57K
-0.007x -12597.48%
2016-03-31 Rs9.48 Billion
≈ $102.51 Million
Rs-540.00K
≈ $-5.84K
0.000x +99.94%
2015-03-31 Rs2.38 Billion
≈ $25.76 Million
Rs-235.49 Million
≈ $-2.55 Million
-0.099x +86.47%
2014-03-31 Rs613.06 Million
≈ $6.63 Million
Rs-447.85 Million
≈ $-4.84 Million
-0.731x -1803.87%
2013-03-31 Rs995.83 Million
≈ $10.77 Million
Rs-38.21 Million
≈ $-413.23K
-0.038x -116.25%
2012-03-31 Rs1.28 Billion
≈ $13.84 Million
Rs302.36 Million
≈ $3.27 Million
0.236x -37.08%
2011-03-31 Rs1.35 Billion
≈ $14.60 Million
Rs506.60 Million
≈ $5.48 Million
0.375x +148.36%
2010-03-31 Rs1.12 Billion
≈ $12.09 Million
Rs168.95 Million
≈ $1.83 Million
0.151x +223.00%
2009-03-31 Rs405.20 Million
≈ $4.38 Million
Rs-49.79 Million
≈ $-538.46K
-0.123x -14561.60%
2008-03-31 Rs573.71 Million
≈ $6.20 Million
Rs487.47K
≈ $5.27K
0.001x -99.26%
2007-03-31 Rs349.24 Million
≈ $3.78 Million
Rs40.21 Million
≈ $434.91K
0.115x -68.51%
2006-03-31 Rs198.08 Million
≈ $2.14 Million
Rs72.43 Million
≈ $783.26K
0.366x --

About Viyash Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic
Market Cap
$529.07 Million
Rs48.92 Billion INR
Market Cap Rank
#12005 Global
#599 in India
Share Price
Rs193.72
Change (1 day)
-3.70%
52-Week Range
Rs169.37 - Rs252.00
All Time High
Rs322.89
About

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more